$HCSG
HEALTHCARE SERVICES GROUP INC Stock $hcsg

$hcsg Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000073101223000103 Filed on July 28, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$411.4M	$418.9M
YoY Change	-0.75%	-1.39%
Cost Of Revenue	$377.6M	$367.7M
YoY Change	0.18%	-3.07%
Gross Profit	$33.83M	$51.20M
YoY Change	-10.0%	12.57%
Gross Profit Margin	8.22%	12.22%
Selling, General & Admin	$39.05M	$41.43M
YoY Change	9.06%	41.49%
% of Gross Profit	115.41%	80.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.500M	$3.595M
YoY Change	-3.85%	49.79%
% of Gross Profit	7.39%	7.02%
Operating Expenses	$39.05M	$41.43M
YoY Change	9.06%	41.49%
Operating Profit	-$5.213M	$9.774M
YoY Change	-391.07%	-39.69%
Interest Expense	-$2.132M	$1.636M
YoY Change	166.83%	-467.57%
% of Operating Profit		16.73%
Other Income/Expense, Net
YoY Change
Pretax Income	-$6.951M	$11.41M
YoY Change	-800.0%	38.3%
Income Tax	-$1.457M	$2.812M
% Of Pretax Income		24.65%
Net Earnings	-$5.494M	$8.598M
YoY Change	-1806.21%	26.07%
Net Earnings / Revenue	-1.34%	2.05%
Basic Earnings Per Share	-$0.07	$0.12
Diluted Earnings Per Share	-$0.07	$0.12
COMMON SHARES
Basic Shares Outstanding	74.20M shares	74.20M shares
Diluted Shares Outstanding	74.36M shares	74.57M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$121.3M	$121.8M
YoY Change	6.98%	-5.67%
Cash & Equivalents	$31.31M	$28.66M
Short-Term Investments	$90.00M	$93.19M
Other Short-Term Assets	$23.90M	$26.28M
YoY Change	-53.88%	-22.35%
Inventory	$19.20M	$19.98M
Prepaid Expenses	$23.88M	$26.28M
Receivables	$367.8M	$380.1M
Other Receivables	$1.200M	$926.0K
Total Short-Term Assets	$533.4M	$549.1M
YoY Change	4.03%	5.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$29.10M	$26.93M
YoY Change	20.03%	5.07%
Goodwill	$75.53M	$75.53M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.814M	$65.93M
YoY Change	-97.24%	0.24%
Total Long-Term Assets	$217.4M	$212.7M
YoY Change	3.76%	-2.54%
TOTAL ASSETS
Total Short-Term Assets	$533.4M	$549.1M
Total Long-Term Assets	$217.4M	$212.7M
Total Assets	$750.7M	$761.8M
YoY Change	3.95%	2.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$70.59M	$65.62M
YoY Change	4.61%	-1.27%
Accrued Expenses	$69.60M	$81.24M
YoY Change	165.22%	-20.95%
Deferred Revenue
YoY Change
Short-Term Debt	$45.00M	$40.00M
YoY Change	80.0%	300.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$187.8M	$189.7M
YoY Change	3.27%	3.12%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.123M	$121.5M
YoY Change	-60.98%	1796.74%
Total Long-Term Liabilities	$3.123M	$121.5M
YoY Change	-60.98%	1796.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$187.8M	$189.7M
Total Long-Term Liabilities	$3.123M	$121.5M
Total Liabilities	$190.9M	$311.2M
YoY Change	0.56%	63.48%
SHAREHOLDERS EQUITY
Retained Earnings	$170.3M	$175.8M
YoY Change	10.23%	3.25%
Common Stock	$308.9M	$306.6M
YoY Change	2.63%	2.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$441.7M	$450.6M
YoY Change
Total Liabilities & Shareholders Equity	$750.7M	$761.8M
YoY Change	3.95%	2.93%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$5.494M	$8.598M
YoY Change	-1806.21%	26.07%
Depreciation, Depletion And Amortization	$2.500M	$3.595M
YoY Change	-3.85%	49.79%
Cash From Operating Activities	$3.000M	$7.403M
YoY Change	-130.32%	-17.91%
INVESTING ACTIVITIES
Capital Expenditures	$1.900M	$1.087M
YoY Change	-221.64%	-192.67%
Acquisitions
YoY Change
Other Investing Activities	$600.0K	$1.193M
YoY Change	117.39%	-82.21%
Cash From Investing Activities	-$1.300M	$106.0K
YoY Change	1.09%	-98.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.000M	5.000M
YoY Change	-215.47%	-131.71%
NET CHANGE
Cash From Operating Activities	3.000M	7.403M
Cash From Investing Activities	-1.300M	106.0K
Cash From Financing Activities	1.000M	5.000M
Net Change In Cash	2.700M	12.51M
YoY Change	-122.41%	-1127.01%
FREE CASH FLOW
Cash From Operating Activities	$3.000M	$7.403M
Capital Expenditures	$1.900M	$1.087M
Free Cash Flow	$1.100M	$6.316M
YoY Change	-113.2%	-38.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	24.68
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://hcsgcorp.com/20230630#PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://hcsgcorp.com/20230630#PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	452677000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	11329000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-5269000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6060000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	410000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1069000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2298000	usd
CY2022Q1	hcsg	Stock Issued During Period Value Treasury Stock Reissued Deferred Compensation Net StockIssuedDuringPeriodValueTreasuryStockReissuedDeferredCompensationNet	524000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1512000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.21
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	15859000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	25000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	59000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	446637000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	6820000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1945000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4875000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2292000	usd
CY2022Q2	hcsg	Stock Issued During Period Value Treasury Stock Reissued Deferred Compensation Net StockIssuedDuringPeriodValueTreasuryStockReissuedDeferredCompensationNet	-5000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.21
CY2022Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	15980000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	26000	usd
	hcsg	Revenue From Contract With Customer Renewal Term RevenueFromContractWithCustomerRenewalTerm	P1Y
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Use Of Estimates UseOfEstimates	In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.
	us-gaap	Contract With Customer Timing Of Satisfaction Of Performance Obligation And Payment ContractWithCustomerTimingOfSatisfactionOfPerformanceObligationAndPayment	The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however most promissory notes mature over 1 to 4 years. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit losses
	hcsg	Period Of Amortization Of Inventories And Supplies PeriodOfAmortizationOfInventoriesAndSupplies	P24M
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At June 30, 2023 and December 31, 2022, the majority of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the Company’s customers participate. As a result, the Company may not realize the full effects such programs may have on the Company’s customers until such new legislation or changes in existing regulations are fully implemented and governmental agencies issue applicable regulations or guidance.</span></div>
CY2023Q2	hcsg	Concentration Risk Numberof Financial Institutions Holding Cashand Cash Equivalentsand Marketable Securities ConcentrationRiskNumberofFinancialInstitutionsHoldingCashandCashEquivalentsandMarketableSecurities	1	institution
CY2022Q4	hcsg	Concentration Risk Numberof Financial Institutions Holding Cashand Cash Equivalentsand Marketable Securities ConcentrationRiskNumberofFinancialInstitutionsHoldingCashandCashEquivalentsandMarketableSecurities	1	institution
	hcsg	Revenue From Contract With Customer Renewal Term RevenueFromContractWithCustomerRenewalTerm	P1Y
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1800000	usd
	us-gaap	Revenue Performance Obligation Description Of Timing RevenuePerformanceObligationDescriptionOfTiming	The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.
	hcsg	Revenue From Contract With Customer Renewal Term RevenueFromContractWithCustomerRenewalTerm	P1Y
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	66100000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q2	hcsg	Accounts Notes Loansand Financing Receivable Gross Current AccountsNotesLoansandFinancingReceivableGrossCurrent	455806000	usd
CY2022Q4	hcsg	Accounts Notes Loansand Financing Receivable Gross Current AccountsNotesLoansandFinancingReceivableGrossCurrent	406969000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	75745000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	70192000	usd
CY2023Q2	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	380061000	usd
CY2022Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	336777000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Gross Noncurrent NotesAndLoansReceivableGrossNoncurrent	34657000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Gross Noncurrent NotesAndLoansReceivableGrossNoncurrent	35882000	usd
CY2023Q2	us-gaap	Allowance For Notes And Loans Receivable Noncurrent AllowanceForNotesAndLoansReceivableNoncurrent	3917000	usd
CY2022Q4	us-gaap	Allowance For Notes And Loans Receivable Noncurrent AllowanceForNotesAndLoansReceivableNoncurrent	3273000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	30740000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	32609000	usd
CY2023Q2	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	410801000	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	369386000	usd
CY2023Q2	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	700000	usd
CY2022Q2	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	500000	usd
	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	1300000	usd
	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	800000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	100000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	49411000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	707000	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13899000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	62603000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13681000	usd
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	538000	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff Year One Originated Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffYearOneOriginatedCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	101000	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff Originated More Than Five Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	53000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	154000	usd
	hcsg	Financing Receivable Allowance For Credit Loss Recovery Year One Originated Current Fiscal Year FinancingReceivableAllowanceForCreditLossRecoveryYearOneOriginatedCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Recovery Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossRecoveryYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Recovery Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossRecoveryYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Recovery Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossRecoveryYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Recovery Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossRecoveryYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Recovery Originated More Than Five Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossRecoveryOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	0	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year One Originated Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearOneOriginatedCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	101000	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff After Recovery Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	0	usd
	hcsg	Financing Receivable Allowance For Credit Loss Writeoff After Recovery Originated More Than Five Years Before Current Fiscal Year FinancingReceivableAllowanceForCreditLossWriteoffAfterRecoveryOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	53000	usd
	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	154000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	68407000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	8365000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10378000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	70420000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	8460000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	103000	usd
CY2023Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	885000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9242000	usd
CY2023Q1	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	76867000	usd
CY2023Q2	hcsg	Accounts And Financing Receivable Allowance For Credit Loss Writeoff AccountsAndFinancingReceivableAllowanceForCreditLossWriteoff	8468000	usd
CY2023Q2	hcsg	Accounts And Financing Receivable Credit Loss Expense Reversal AccountsAndFinancingReceivableCreditLossExpenseReversal	11263000	usd
CY2023Q2	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	79662000	usd
CY2022Q2	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	274000	usd
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13417000	usd
CY2022Q1	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	63092000	usd
CY2022Q2	hcsg	Accounts And Financing Receivable Allowance For Credit Loss Writeoff AccountsAndFinancingReceivableAllowanceForCreditLossWriteoff	1245000	usd
CY2022Q2	hcsg	Accounts And Financing Receivable Credit Loss Expense Reversal AccountsAndFinancingReceivableCreditLossExpenseReversal	14173000	usd
CY2022Q2	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	76020000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	66601000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	11818000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15637000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	70420000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6863000	usd
	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	154000	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	2533000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9242000	usd
CY2022Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	73464000	usd
	hcsg	Accounts And Financing Receivable Allowance For Credit Loss Writeoff AccountsAndFinancingReceivableAllowanceForCreditLossWriteoff	11972000	usd
	hcsg	Accounts And Financing Receivable Credit Loss Expense Reversal AccountsAndFinancingReceivableCreditLossExpenseReversal	18170000	usd
CY2023Q2	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	79662000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	100000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	50794000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	6050000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	17859000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	62603000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	14790000	usd
	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	538000	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-835000	usd
CY2022Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13417000	usd
CY2021Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	65584000	usd
	hcsg	Accounts And Financing Receivable Allowance For Credit Loss Writeoff AccountsAndFinancingReceivableAllowanceForCreditLossWriteoff	6588000	usd
	hcsg	Accounts And Financing Receivable Credit Loss Expense Reversal AccountsAndFinancingReceivableCreditLossExpenseReversal	17024000	usd
CY2022Q2	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	76020000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	200000	usd
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	344000	usd
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-7234000	usd
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-3000	usd
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-20000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	347000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-7214000	usd
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	100000	usd
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	100000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	100000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-1900000	usd
CY2023Q2	hcsg	Operating Lease Right Of Use Asset Before Accumulated Amortization OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization	25838000	usd
CY2022Q4	hcsg	Operating Lease Right Of Use Asset Before Accumulated Amortization OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization	34445000	usd
CY2023Q2	hcsg	Property Plant And Equipment And Operating Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	47516000	usd
CY2022Q4	hcsg	Property Plant And Equipment And Operating Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	55171000	usd
CY2023Q2	hcsg	Property Plant And Equipment And Operating Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	20584000	usd
CY2022Q4	hcsg	Property Plant And Equipment And Operating Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	32196000	usd
CY2023Q2	hcsg	Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	26932000	usd
CY2022Q4	hcsg	Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	22975000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	2400000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	2400000	usd
	us-gaap	Depreciation Depreciation	4900000	usd
	us-gaap	Depreciation Depreciation	5300000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1600000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2800000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1500000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3100000	usd
	hcsg	Lessee Operating Lease Termination Option Term LesseeOperatingLeaseTerminationOptionTerm	P1Y
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1444000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	1528000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	422000	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	225000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	633000	usd
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	245000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	2499000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	1998000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2831000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2915000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	654000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	580000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	1083000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	327000	usd
	us-gaap	Lease Cost LeaseCost	4568000	usd
	us-gaap	Lease Cost LeaseCost	3822000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3110000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	3300000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043
CY2023Q2	hcsg	Right Of Use Asset And Operating Lease Liability Decrease Due To Cancellation RightOfUseAssetAndOperatingLeaseLiabilityDecreaseDueToCancellation	400000	usd
	hcsg	Right Of Use Asset And Operating Lease Liability Decrease Due To Cancellation RightOfUseAssetAndOperatingLeaseLiabilityDecreaseDueToCancellation	1100000	usd
CY2022Q2	hcsg	Right Of Use Asset And Operating Lease Liability Decrease Due To Cancellation RightOfUseAssetAndOperatingLeaseLiabilityDecreaseDueToCancellation	500000	usd
	hcsg	Right Of Use Asset And Operating Lease Liability Decrease Due To Cancellation RightOfUseAssetAndOperatingLeaseLiabilityDecreaseDueToCancellation	1400000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	3412000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6070000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4833000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2405000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1365000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1389000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	116000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	19590000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1990000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	17600000	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1412000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2685000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2685000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2666000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1195000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	613000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2283000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-900000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-300000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1900000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-7200000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-600000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-200000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-200000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1900000	usd
CY2023Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	2300000	usd
CY2022Q2	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	6500000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	3800000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	10600000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	97147000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	194000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4156000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	99601000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	229000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4630000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	95200000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	139000	shares
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	5723000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2798000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	32436000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	35068000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	39265000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	38575000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	15761000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	18759000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	93185000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	95200000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4409000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4768000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4409000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4768000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	21200000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2375000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.56
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	207000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.72
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2443000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.43
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.53
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.06
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.040
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.015
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y8M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.395
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.366
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.046
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	251000	usd
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1705000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	34.73
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y7M6D
CY2023Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1100000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	600000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	418931000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	424857000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	836161000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	851668000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11410000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8250000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	28966000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	24031000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	8598000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	6820000	usd
	us-gaap	Net Income Loss NetIncomeLoss	21282000	usd
	us-gaap	Net Income Loss NetIncomeLoss	18149000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74478000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74337000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74488000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74332000	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	89000	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	21000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	55000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	13000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74567000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74358000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74543000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74345000	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3077000	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2947000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2721000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3158000	shares
CY2023Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	300000000	usd
CY2023Q2	us-gaap	Line Of Credit LineOfCredit	40000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	25000000	usd
CY2023Q2	hcsg	Debt Instrument Covenant Number DebtInstrumentCovenantNumber	2	covenant
	hcsg	Lineof Credit Facility Increase Decrease Remaining Borrowing Capacity LineofCreditFacilityIncreaseDecreaseRemainingBorrowingCapacity	-85700000	usd
CY2023Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	174300000	usd

Files In Submission

Name	View Source	Status
0000731012-23-000103-index-headers.html	Edgar Link	pending
0000731012-23-000103-index.html	Edgar Link	pending
0000731012-23-000103.txt	Edgar Link	pending
0000731012-23-000103-xbrl.zip	Edgar Link	pending
ex311section302certificati.htm	Edgar Link	pending
ex312section302certificati.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hcsg-20230630.htm	Edgar Link	pending
hcsg-20230630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hcsg-20230630_cal.xml	Edgar Link	unprocessable
hcsg-20230630_def.xml	Edgar Link	unprocessable
hcsg-20230630_lab.xml	Edgar Link	unprocessable
hcsg-20230630_pre.xml	Edgar Link	unprocessable
hcsg-20230630_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
section906certificationq22.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HCSG
HEALTHCARE SERVICES GROUP INC Stock $hcsg

2023 Q3 Form 10-Q Financial Statement

#000073101223000103 Filed on July 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCSG HEALTHCARE SERVICES GROUP INC Stock $hcsg

2023 Q3 Form 10-Q Financial Statement

#000073101223000103 Filed on July 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCSG
HEALTHCARE SERVICES GROUP INC Stock $hcsg